Emergent BioSolutions

Contributing Author

Recent Articles by Emergent BioSolutions

Jul-15	Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025 EBS GlobeNewswire
Jul-08	Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016 [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts EBS GlobeNewswire
Jul-02	Emergent BioSolutions Expands NARCANDirect to Offer KLOXXADO (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate EBS GlobeNewswire
Jun-23	Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] to Bolster U.S. Biodefense Supply EBS GlobeNewswire
Jun-20	Emergent BioSolutions Announces Addition to Russell 3000 Index EBS GlobeNewswire
Jun-05	Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies EBS GlobeNewswire
May-14	Emergent BioSolutions to Participate in Upcoming Investor Conferences EBS GlobeNewswire
May-07	Emergent BioSolutions Reports First Quarter 2025 Financial Results EBS GlobeNewswire
May-01	Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health EBS GlobeNewswire